Medico Intercontinental Ltd
Incorporated in 1914, Medico Intercontinental
Ltd is engaged in trading of Pharmaceutical products[1]
- Market Cap ₹ 40.9 Cr.
- Current Price ₹ 40.9
- High / Low ₹ 63.6 / 34.2
- Stock P/E 8.08
- Book Value ₹ 48.6
- Dividend Yield 0.00 %
- ROCE 13.8 %
- ROE 10.8 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.84 times its book value
- Company is expected to give good quarter
Cons
- The company has delivered a poor sales growth of 3.22% over past five years.
- Company has a low return on equity of 10.8% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
0.00 | 9.95 | 81.93 | 69.74 | 74.26 | 76.23 | 71.33 | 96.02 | |
0.34 | 9.29 | 77.57 | 64.97 | 69.25 | 70.97 | 65.50 | 87.60 | |
Operating Profit | -0.34 | 0.66 | 4.36 | 4.77 | 5.01 | 5.26 | 5.83 | 8.42 |
OPM % | 6.63% | 5.32% | 6.84% | 6.75% | 6.90% | 8.17% | 8.77% | |
0.39 | 0.36 | 0.05 | 0.18 | 0.31 | 0.51 | 0.40 | 0.36 | |
Interest | 0.00 | 0.01 | 1.10 | 1.28 | 0.88 | 0.62 | 0.50 | 1.00 |
Depreciation | 0.00 | 0.00 | 0.10 | 0.14 | 0.21 | 0.20 | 0.29 | 0.81 |
Profit before tax | 0.05 | 1.01 | 3.21 | 3.53 | 4.23 | 4.95 | 5.44 | 6.97 |
Tax % | 40.00% | 26.73% | 26.17% | 26.91% | 26.71% | 27.07% | 27.39% | 27.55% |
0.03 | 0.74 | 2.36 | 2.58 | 3.10 | 3.61 | 3.95 | 5.06 | |
EPS in Rs | 0.09 | 2.28 | 7.26 | 7.94 | 9.54 | 3.61 | 3.95 | 5.06 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.77% | 2.53% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 3% |
3 Years: | 9% |
TTM: | 35% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 16% |
3 Years: | 18% |
TTM: | 28% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 11% |
1 Year: | -6% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 13% |
3 Years: | 11% |
Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 10.00 | 10.00 | 10.00 |
Reserves | 0.02 | 0.75 | 3.11 | 6.29 | 9.39 | 31.19 | 35.03 | 38.65 |
0.02 | 0.11 | 13.66 | 9.31 | 8.73 | 4.72 | 4.86 | 16.92 | |
0.62 | 5.02 | 16.02 | 11.80 | 10.55 | 12.97 | 6.16 | 10.19 | |
Total Liabilities | 3.91 | 9.13 | 36.04 | 30.65 | 31.92 | 58.88 | 56.05 | 75.76 |
0.01 | 0.00 | 1.68 | 2.35 | 2.36 | 2.57 | 3.52 | 8.69 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.16 | 0.01 | 0.02 | 0.02 | 0.02 |
3.90 | 9.13 | 34.36 | 28.14 | 29.55 | 56.29 | 52.51 | 67.05 | |
Total Assets | 3.91 | 9.13 | 36.04 | 30.65 | 31.92 | 58.88 | 56.05 | 75.76 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
0.02 | 0.93 | -13.82 | 5.82 | 3.85 | -10.10 | 5.58 | -7.11 | |
0.00 | 0.00 | 0.00 | -0.94 | -1.30 | -5.38 | -8.54 | -2.19 | |
0.00 | 0.09 | 13.42 | -5.14 | -1.20 | 20.41 | -0.46 | 8.63 | |
Net Cash Flow | 0.02 | 1.02 | -0.40 | -0.26 | 1.35 | 4.92 | -3.42 | -0.68 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 237.34 | 101.44 | 94.10 | 84.25 | 157.29 | 118.77 | 124.87 | |
Inventory Days | 0.00 | 25.84 | 45.69 | 57.71 | 47.27 | 52.03 | 69.45 | 45.20 |
Days Payable | 201.37 | 73.54 | 66.83 | 50.21 | 66.73 | 29.93 | 36.54 | |
Cash Conversion Cycle | 61.81 | 73.59 | 84.98 | 81.31 | 142.58 | 158.28 | 133.53 | |
Working Capital Days | 78.14 | 74.44 | 81.07 | 77.36 | 143.93 | 148.96 | 169.46 | |
ROCE % | 27.57% | 35.72% | 24.75% | 25.41% | 16.56% | 12.40% | 13.81% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 31 May
-
Intimation For Appointment / Re-Appointment Of Auditors.
30 May - Appointed Agarwal & Mehta as secretarial auditor (5 years) and re-appointed MJV & Co as internal auditor (1 year).
- Results - Financial Year Ended 31/03/2025 30 May
-
Board Meeting Outcome for Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
30 May - Audited standalone and consolidated FY2025 financial results approved; auditor appointments disclosed.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
24 May - Annual Secretarial Compliance Report confirming full SEBI compliance for FY ended March 31, 2025.
Business Overview:[1][2]
MIL (Formerly M/S. Intercontinental Leasing
& Finance Company Limited) was in the textile business. Currently, it trades pharmaceutical products related to Gastro, Uro, Nutrition, Cosmetology, Health Devices, Hospital,
etc.